Commercial 4 Industry Execs Examine the State of Physician-Rep Access

4 Industry Execs Examine the State of Physician-Rep Access

Recent polls paint a mixed picture of physicians' willingness to see pharma sales reps. What gives? Are no-see docs up or down, and what's behind the dissonant findings?

Commercial Marketers Rely on Email and Social Media, Rather than Face Time

Marketers Rely on Email and Social Media, Rather than Face Time

Curating personal relationships is one of the most valuable functions medical marketers can provide. The best way is through face-to-face interaction.

Commercial Five things for pharma marketers to know: Thursday, January 28, 2016

Five things for pharma marketers to know: Thursday, January 28, 2016

Sales of cystic-fibrosis drug Orkambi higher than expected; new sensor tracks sweat; J&J develops clinical trial to find new way to treat depression

Commercial Five things for pharma marketers to know: Tuesday, December 22, 2015

Five things for pharma marketers to know: Tuesday, December 22, 2015

Valeant says it lost few reps despite business scrutiny; Novartis CEO says drugmakers must share benefits of new medicines with other healthcare stakeholders; Bloomberg analysis finds US pays more for branded drugs after discounts

Agency PDI stockholders to vote on commercial services sale

PDI stockholders to vote on commercial services sale

The contract sales organization plans to sell its commercial services business to Publicis Healthcare Communications Group.

Data/Analytics Is pharma's access to physicians decreasing or increasing?

Is pharma's access to physicians decreasing or increasing?

A pair of surveys paint a complicated picture of what direction pharma access to healthcare providers is going.

Data/Analytics Smart devices will improve pharma sales: survey

Smart devices will improve pharma sales: survey

Accenture found that life-sciences executives believe that smart tools and devices will be the catalyst for drugmakers to move forward with beyond-the-pill initiatives.

Pipeline The FDA approves sex-drive pill, Addyi

The FDA approves sex-drive pill, Addyi

Sprout plans to hire 200 sales reps, targeting 30,000 doctors, to accompany the drug's launch.

Pharmaceutical Five things for pharma marketers to know: Thursday, July 30

Five things for pharma marketers to know: Thursday, July 30

Copaxone sales rise despite generic competition; Valeant to defend tax strategy; Bristol-Myers Squibb to test Opdivo with mogamulizumab in the US

Pharmaceutical Graphic: the new hepatitis-C drug market

Graphic: the new hepatitis-C drug market

View on a quarter-by-quarter basis the competitive market for four new hepatitis-C treatments and track how Gilead Sciences' Harvoni became the market leader within months of receiving approval from the FDA.